Literature DB >> 3761193

Tubular sites of furosemide natriuresis in volume-replaced and volume-depleted conscious rats.

S Christensen, E Steiness, H Christensen.   

Abstract

There is accumulating evidence that the renal Li clearance reflects the delivery of Na and volume out of the proximal tubules. In the present study we used the Li clearance technique to evaluate the effects of submaximal furosemide (Fur) infusion (7.5 mg/kg/hr) on proximal and distal Na reabsorption in conscious rats with and without volume replacement with saline. Li was given as an p.o. test dose (0.5 mmol/kg) and [3H]inulin was infused in saline to measure the glomerular filtration rate (GFR). In control rats not infused with F, fractional Na excretion was about 1% and fractional Li excretion was about 30 to 35%. Infusion of F with constant rate and volume replacement increased fractional Na excretion to 22% and fractional Li excretion to 57% associated with a small decrease of the GFR. Without volume replacement F infusion caused a smaller and temporary diuretic and natriuretic response (maximum fractional Na excretion = 7.5%) followed by a decrease of urine flow and Na excretion almost to control levels, despite continued high excretion rates of F. The GFR decreased by 25% and fractional Li excretion showed an initial increase followed by return to baseline levels. The results suggest that in conscious rats submaximal doses of F cause major inhibition of proximal tubular Na reabsorption, which effect contributes substantially to the initial natriuresis. Along with diuretic-induced volume contraction, the natriuretic response is abolished due to a fall in GFR and particularly due to a secondary increase in fractional Na reabsorption, which occurs both in proximal distal tubular nephron segments.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3761193

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Optimization of the therapeutic index by adjustment of the rate of drug administration or use of drug combinations: exploratory studies of diuretics.

Authors:  J Zhi; G Levy
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

2.  Effect of chronic oral furosemide administration on the 24-hour cycle of lithium clearance and electrolyte excretion in humans.

Authors:  M Shalmi; H Rasmusen; O Amtorp; S Christensen
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 4.  Clinical pharmacology of loop diuretics.

Authors:  D C Brater
Journal:  Drugs       Date:  1991       Impact factor: 9.546

5.  Development of acute tolerance to bumetanide: constant-rate infusion studies.

Authors:  J A Cook; D E Smith
Journal:  Pharm Res       Date:  1988-02       Impact factor: 4.200

6.  A quantitative method of evaluating the diuretic response to furosemide in rats.

Authors:  R Hori; K Okumura; K Inui; T Shibata; T Kikkoji; A Kamiya
Journal:  Pharm Res       Date:  1988-11       Impact factor: 4.200

7.  Effect of frusemide on lithium clearance and proximal tubular reabsorption in anaesthetized rats.

Authors:  S J Walter; D G Shirley
Journal:  J Physiol       Date:  1991-06       Impact factor: 5.182

8.  Effects of furosemide on renal haemodynamics and proximal tubular sodium reabsorption in conscious rats.

Authors:  S Christensen; J S Petersen
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

9.  Mechanisms of renal vasoconstriction following furosemide in conscious rats.

Authors:  B J Janssen; P H Eerdmans; J F Smits
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-05       Impact factor: 3.000

10.  Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine.

Authors:  Maria M Federik Fernandez; Daniel Gonzalez; Jan M Williams; Richard J Roman; Susana Nowicki
Journal:  Eur J Pharmacol       Date:  2012-05-02       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.